Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$517M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$516M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$306M |
| 4 |
Meta Platforms (Facebook)
META
|
+$296M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$441M |
| 2 |
Duke Energy
DUK
|
+$407M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$267M |
| 4 |
Alibaba
BABA
|
+$245M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.71% |
| 2 | Financials | 4.45% |
| 3 | Healthcare | 3.9% |
| 4 | Communication Services | 2.83% |
| 5 | Consumer Discretionary | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCLN
4376
CALL
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $151K | ﹤0.01% |
14,000
| – | – |
|
|
CZR
4377
DELISTED
Caesars Entertainment Corporation
CZR
| $151K | ﹤0.01% |
17,785
-30,020
| -63% | -$225K |
|
4378
PUT
Vanda Pharmaceuticals
VNDA
$308M
| $150K | ﹤0.01% |
9,400
+7,300
| +348% | +$117K |
|
|
MDR
4379
PUT
DELISTED
McDermott International
MDR
| $150K | ﹤0.01% |
6,767
-33
| -0.5% | -$615 |
|
|
FRED
4380
DELISTED
Fred's Inc
FRED
| $150K | ﹤0.01% |
8,098
+7,217
| +819% | +$78.1K |
|
4381
CALL
Commault Systems
CVLT
$5.53B
| $149K | ﹤0.01% |
+2,900
| New | +$156K |
|
4382
Ezcorp Inc
EZPW
$1.8B
| $149K | ﹤0.01% |
13,948
+12,069
| +642% | +$130K |
|
4383
abrdn Physical Gold Shares ETF
SGOL
$7.25B
| $149K | ﹤0.01% |
13,300
| – | – |
|
4384
Vanguard FTSE All-World ex-US ETF
VEU
$67.8B
| $149K | ﹤0.01% |
3,372
+3,298
| +4,457% | +$146K |
|
|
NXTM
4385
DELISTED
NxStage Medical Inc.
NXTM
| $149K | ﹤0.01% |
5,689
-59,124
| -91% | -$1.46M |
|
4386
Ardelyx
ARDX
$1.2B
| $148K | ﹤0.01% |
10,461
+10,006
| +2,199% | +$142K |
|
4387
Greif
GEF
$5.07B
| $148K | ﹤0.01% |
2,891
+2,208
| +323% | +$112K |
|
4388
LifeVantage
LFVN
$83M
| $148K | ﹤0.01% |
18,124
-16,739
| -48% | -$143K |
|
4389
Intellia Therapeutics
NTLA
$1.57B
| $148K | ﹤0.01% |
11,213
+11,145
| +16,390% | +$167K |
|
4390
Walker & Dunlop
WD
$1.52B
| $148K | ﹤0.01% |
4,718
+1,346
| +40% | +$37.7K |
|
4391
W&T Offshore
WTI
$497M
| $148K | ﹤0.01% |
53,372
+52,912
| +11,503% | +$98.4K |
|
|
UFS
4392
CALL
DELISTED
DOMTAR CORPORATION (New)
UFS
| $148K | ﹤0.01% |
3,800
+3,600
| +1,800% | +$137K |
|
4393
CALL
Ameren
AEE
$30B
| $147K | ﹤0.01% |
2,800
+1,300
| +87% | +$64.5K |
|
4394
Cato Corp
CATO
$65.9M
| $147K | ﹤0.01% |
4,865
-5,601
| -54% | -$172K |
|
4395
CALL
Match Group
MTCH
$8.54B
| $147K | ﹤0.01% |
8,600
-13,700
| -61% | -$243K |
|
4396
Sony
SONY
$136B
| $147K | ﹤0.01% |
26,215
-965
| -4% | -$5.86K |
|
|
OTIC
4397
DELISTED
Otonomy, Inc.
OTIC
| $147K | ﹤0.01% |
9,368
-13,866
| -60% | -$232K |
|
|
INWK
4398
DELISTED
InnerWorkings, Inc.
INWK
| $147K | ﹤0.01% |
14,876
-219
| -1% | -$2.03K |
|
|
BGG
4399
CALL
DELISTED
Briggs & Stratton Corp.
BGG
| $147K | ﹤0.01% |
+6,600
| New | +$134K |
|
4400
MiMedx Group
MDXG
$609M
| $146K | ﹤0.01% |
16,582
+14,296
| +625% | +$128K |
|
Similar funds
Barclays's Q4 2016 Portfolio in Review
As of Q4 2016, Barclays held 7,178 positions worth $92.5B, up 2.7% from $90.1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays's Q4 2016 filing shows 490 new, 3,383 increased, 2,405 reduced and 438 closed positions. Its largest new stake was Howmet Aerospace: 1,639,920 shares worth $23.3M. The largest sale was Procter & Gamble, an estimated $441M.
By sector, the portfolio is most concentrated in Technology at 4.7% of assets, up from 4.5% a quarter earlier, followed by Financials and Healthcare.
- Barclays's largest Q4 2016 buy was Howmet Aerospace: 1,639,920 shares worth $23.3M.
- Barclays added most to State Street Technology Select Sector SPDR ETF in Q4 2016, an estimated $517M increase.
- Barclays's biggest Q4 2016 reduction was Procter & Gamble, cutting an estimated $441M.
- Barclays fully exited LinkedIn Corporation in Q4 2016, selling an estimated $223M.
- Barclays's ten largest holdings make up 34% of its $92.5B portfolio in Q4 2016.
- Barclays opened 490 new positions and closed 438 in Q4 2016.
- Barclays's portfolio value rose 2.7% quarter-over-quarter to $92.5B.
Based on Barclays's 13F filing for Q4 2016, filed 14 Feb 2017.